AstraZeneca PLC (JOBS) CEO Says Firm Mulls Branded Generic Buy in Emerging Markets

September 24, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON (MarketWatch) -- AstraZeneca PLC will consider acquiring branded generic drugs in emerging countries as it boosts its business outside the U.S. and Europe, Chief Executive David Brennan said Tuesday.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe

AstraZeneca Pharmaceuticals LP